Utilizing DreaMed Diabetes’s Advisor Pro software, the prestigious health system will onboard 100 people with diabetes to assess the workflow, satisfaction, and financial aspects of an AI-based ...
The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes. “This is an innovation that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results